Jin Medical International Ltd. ZJYL

Annual Quarterly

FY2025 · ended Sep 30, 2025 · Revenue $20.69M, -12.0% YoY · Filed Feb 10, 2026

Jin Medical International Ltd. (ZJYL) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $20.7 million and net income of $1.2 million. Free cash flow was -$3.7 million. As of Sep 30, 2025 it held $29.6 million in cash and investments and $18.9 million in total debt.

Revenue
$20.69M
-12.0% vs prior year
Net income
$1.19M
-67.6% vs prior year
Operating cash flow
$2.90M
+340.5% vs prior year
Free cash flow
$-3.73M
-175.6% vs prior year
EPS
$0.01
-50.0% vs prior year
Dividend per share
None
Shares outstanding
156.55M
+0.0% vs prior year
Net cash
$10.72M
FY 2025
Operating margin
2.9%
FY 2025

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
ZJYL (Nasdaq)
Fiscal year ends
September 30
Incorporated in
Cayman Islands
Headquarters
Jiangsu Province, China
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1837821

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
FY 2023
Sep 30, 2023
Revenue
$20.7M
$23.5M
$19.8M
Operating income
$608,182
$3.6M
$2.9M
Net income
$1.2M
$3.7M
$2.9M
Diluted EPS
$0.01
$0.02
$0.02
Operating cash flow
$2.9M
-$1.2M
$3.1M
Free cash flow
-$3.7M
-$1.4M
$3.0M
Total assets
$53.4M
$45.8M
$32.9M
Total liabilities
$23.8M
$17.2M
$8.9M
Stockholders' equity
$29.6M
$28.8M
$24.0M
Cash and investments
$29.6M
$26.8M
$16.7M
Total debt
$18.9M
$11.6M
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 30, 2026 Oct 30, 2026
6-K Current report (foreign issuer) Sep 24, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Aug 4, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Jul 20, 2026 Jul 20, 2026
6-K Current report (foreign issuer) Jul 15, 2026 Jul 15, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.